{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:34:33Z","timestamp":1787027673495,"version":"build-2736575974"},"reference-count":73,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T00:00:00Z","timestamp":1634601600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Behavioral Sciences"],"abstract":"<jats:p>Although blockade of dopamine receptors D2 and D3 appears to be the main mechanism of antipsychotic action, treatment response variability calls for an examination of other biological systems. Our aim is to systematically review reports of treatment response in delusional disorder (DD) in order to help determine its biological bases. Computerized searches of ClinicalTrials.gov, PubMed, and Scopus databases (from 1999 to September 2021) were systematically reviewed, in keeping with PRISMA directives. We used the search terms: (treat * OR therap * AND (delusional disorder)). We included all studies that explored the biological mechanisms of treatment response in DD, as diagnosed by ICD or DSM criteria. A total of 4344 records were initially retrieved, from which 14 papers were included: case reports, case series, and cohort studies. Findings point to (1) dopaminergic dysfunction (based on biochemical and genetic studies), (2) serotonergic dysfunction (based on partial agonism\/antagonism of drugs), and (3) brain structure\/function impairment, especially in the temporal and parietal lobes, as crucial factors in treatment response. Further studies with higher levels of evidence are needed to help clinicians determine treatment.<\/jats:p>","DOI":"10.3390\/bs11100141","type":"journal-article","created":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T01:23:46Z","timestamp":1634693026000},"page":"141","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Dopamine, Serotonin, and Structure\/Function Brain Defects as Biological Bases for Treatment Response in Delusional Disorder: A Systematic Review of Cases and Cohort Studies"],"prefix":"10.3390","volume":"11","author":[{"given":"Armand","family":"Gu\u00e0rdia","sequence":"first","affiliation":[{"name":"Department of Mental Health, Mutua Terrassa University Hospital, University of Barcelona, 08221 Terrassa, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1855-8566","authenticated-orcid":false,"given":"Alexandre","family":"Gonz\u00e1lez-Rodr\u00edguez","sequence":"additional","affiliation":[{"name":"Department of Mental Health, Mutua Terrassa University Hospital, University of Barcelona, 08221 Terrassa, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6797-3382","authenticated-orcid":false,"given":"Mary V.","family":"Seeman","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Toronto, Toronto, ON M5S 1A1, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7991-7548","authenticated-orcid":false,"given":"Aida","family":"\u00c1lvarez","sequence":"additional","affiliation":[{"name":"Department of Mental Health, Parc Tauli University Hospital, 08280 Sabadell, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesc","family":"Estrada","sequence":"additional","affiliation":[{"name":"Department of Mental Health, Parc Tauli University Hospital, 08280 Sabadell, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sidharta","family":"Acebillo","sequence":"additional","affiliation":[{"name":"Department of Mental Health, Parc Tauli University Hospital, 08280 Sabadell, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2214-1886","authenticated-orcid":false,"given":"Javier","family":"Labad","sequence":"additional","affiliation":[{"name":"Department of Mental Health, Consorci Sanitari del Maresme, Fundaci\u00f3 Parc Taul\u00ed, CIBERSAM, 08340 Matar\u00f3, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 A.","family":"Monreal","sequence":"additional","affiliation":[{"name":"Department of Mental Health, Mutua Terrassa University Hospital, University of Barcelona, 08221 Terrassa, Spain"},{"name":"Neurosciences Institute, Universitat Aut\u00f2noma de Barcelona, CIBERSAM, 08221 Terrassa, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,10,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/JCP.0b013e3182905796","article-title":"Comparative efficacy and acceptability of existing pharmacotherapies for delusional disorder: A retrospective case series and review of the literature","volume":"33","author":"Mews","year":"2013","journal-title":"J. Clin. Psychopharmacol."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association (2013). Diagnostic and Statistical Manual of Mental Disorders: DSM-5\u2122, American Psychiatric Association. [5th ed.].","DOI":"10.1176\/appi.books.9780890425596"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1001\/archpsyc.1982.04290080012003","article-title":"Demography of paranoid psychosis (delusional disorder): A review and comparison with schizophrenia and affective illness","volume":"39","author":"Kendler","year":"1982","journal-title":"Arch. Gen. Psychiatry"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1177\/070674370605100207","article-title":"Recent advances in the treatment of delusional disorder","volume":"51","author":"Manschreck","year":"2006","journal-title":"Can. J. Psychiatry"},{"key":"ref_5","first-page":"37","article-title":"Gender differences in delusional disorder","volume":"35","year":"2015","journal-title":"Rev. Asoc. Esp. Neuropsiq."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"216","DOI":"10.4103\/0253-7176.203123","article-title":"Gender Differences in Persistent Delusional Disorder","volume":"39","author":"Kulkarni","year":"2017","journal-title":"Indian J. Psychol. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s00406-010-0130-1","article-title":"Gender-related features of persistent delusional disorders","volume":"261","author":"Wustmann","year":"2011","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"416","DOI":"10.3109\/00048674.2010.551279","article-title":"Clinical and cognitive correlates of psychiatric comorbidity in delusional disorder outpatients","volume":"45","author":"Haro","year":"2011","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"265","DOI":"10.4321\/S0213-61632013000400005","article-title":"Delusional disorder: An overview of depressive symptoms and antidepressant use","volume":"27","year":"2013","journal-title":"Eur. J. Psychiatry"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.psychres.2010.02.017","article-title":"Gender differences in delusional disorder: Evidence from an outpatient sample","volume":"177","author":"Miriam","year":"2010","journal-title":"Psychiatry Res."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Gonz\u00e1lez-Rodr\u00edguez, A., and Seeman, M.V. (2020). Addressing Delusions in Women and men with delusional disorder: Key Points for Clinical Management. Int. J. Environ. Res. Public Health, 17.","DOI":"10.3390\/ijerph17124583"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1177\/0269881109106959","article-title":"The biological basis of antipsychotic response in schizophrenia","volume":"24","author":"Stone","year":"2010","journal-title":"J. Psychopharmacol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Yang, A.C., and Tsai, S.J. (2017). New targets for schizophrenia treatment beyond the dopamine hypothesis. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18081689"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/archpsyc.1988.01800330013001","article-title":"Clozapine for the treatment-resistant schizophrenic: A double-blind comparison with chlorpromazine","volume":"45","author":"Kane","year":"1988","journal-title":"Arch. Gen. Psychiatry"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1192\/bjp.bp.115.177261","article-title":"Clozapine v. First-and second-generation antipsychotics in treatment-refractory schizophrenia: Systematic review and meta-analysis","volume":"209","author":"Siskind","year":"2016","journal-title":"Br. J. Psychiatry"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/jamapsychiatry.2015.2955","article-title":"Efficacy, acceptability, and tolerability of antipsychotics in treatment-resistant schizophrenia: A network meta-analysis","volume":"73","author":"Samara","year":"2016","journal-title":"JAMA Psychiatry"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0022-3956(74)90081-8","article-title":"Dopamine and the pharmacology of schizophrenia: The state of the evidence","volume":"11","author":"Matthysse","year":"1974","journal-title":"J. Psychiat. Res."},{"key":"ref_18","first-page":"492","article-title":"The significance of dopamine receptor blockade for the action of neuroleptic drugs","volume":"160","year":"1966","journal-title":"Arch. Int. Pharm. Ther."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1600-0773.1963.tb01730.x","article-title":"Effect of chlorpromazine or haloperidol on formation of 3-methoxytyramine and normetanephrine in mouse brain","volume":"20","author":"Carlsson","year":"1963","journal-title":"Acta Pharm. Toxicol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1080\/0964704X.2012.678199","article-title":"History of the discovery of the antipsychotic dopamine D2 receptor: A basis for the dopamine hypothesis of schizophrenia","volume":"22","author":"Madras","year":"2013","journal-title":"J. Hist. Neurosci."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"4376","DOI":"10.1073\/pnas.72.11.4376","article-title":"Brain receptors for antipsychotic drugs and dopamine: Direct binding assays","volume":"72","author":"Seeman","year":"1975","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1126\/science.3854","article-title":"Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs","volume":"192","author":"Creese","year":"1976","journal-title":"Science"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0165-0173(99)00043-0","article-title":"Possible implications of the dopamine D(3) receptor in schizophrenia and in antipsychotic drug actions","volume":"31","author":"Schwartz","year":"2000","journal-title":"Brain Res. Rev."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1001\/archgenpsychiatry.2012.169","article-title":"The nature of dopamine dysfunction in schizophrenia and what this means for treatment","volume":"69","author":"Howes","year":"2012","journal-title":"Arch. Gen. Psychiatry"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1017\/S1092852918001013","article-title":"Beyond the dopamine hypothesis of schizophrenia to three neural networks of psychosis: Dopamine, serotonin, and glutamate","volume":"23","author":"Stahl","year":"2018","journal-title":"CNS Spectr."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1345\/aph.1M721","article-title":"Lurasidone: An atypical antipsychotic for schizophrenia","volume":"46","author":"Risbood","year":"2012","journal-title":"Ann. Pharmacother."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/bsl.683","article-title":"Pharmacotherapy of delusional disorders in the context of offending and the potential for compulsory treatment","volume":"24","author":"Smith","year":"2006","journal-title":"Behav. Sci. Law"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1001\/archpsyc.1995.03950180042006","article-title":"Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in human brain","volume":"52","author":"Volkow","year":"1995","journal-title":"Arch. Gen. Psychiatry"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/S0006-3223(02)01834-6","article-title":"In vivo activity of bupropion at the human dopamine transporter as measured by positron emission tomography","volume":"54","author":"Savitcheva","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1055\/s-2007-1014488","article-title":"Hypothesis: Involvement of the serotonergic system in the clinical expression of monosymptomatic hypochondriasis","volume":"23","author":"King","year":"1990","journal-title":"Pharmacopsychiatry"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1192\/S0007125000298978","article-title":"Monosymptomatic hypochondriacal psychosis","volume":"153","author":"Munro","year":"1988","journal-title":"Br. J. Psychiatry"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/00004583-198803000-00010","article-title":"Case Study; clomipramine treatment of delusional disorder-somatic type","volume":"27","author":"Sondheimer","year":"1988","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1001\/archderm.1978.01640180074018","article-title":"Monosymptomatic hypochondriacal psychosis manifesting as delusions of parasitosis. A description of four cases successfully treated with pimozide","volume":"114","author":"Munro","year":"1978","journal-title":"Arch. Dermatol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1017\/S0033291717000642","article-title":"Brain volume changes over the first year of treatment in schizophrenia: Relationships to antipsychotic treatment","volume":"47","author":"Emsley","year":"2017","journal-title":"Psychol. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"34","DOI":"10.5498\/wjp.v7.i1.34","article-title":"Neuroimaging studies of cognitive remediation in schizophrenia: A systematic and critical review","volume":"7","author":"Segura","year":"2017","journal-title":"World J. Psychiatry"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jclinepi.2017.04.026","article-title":"CARE guidelines for case reports: Explanation and elaboration document","volume":"89","author":"Riley","year":"2017","journal-title":"J. Clin. Epidemiol."},{"key":"ref_38","unstructured":"CLARITY Group at McMaster University (2021, August 10). Tools to Assess Risk of Bias in Cohort Studies, Case Control Studies, Randomized Controlled Trials, and Longitudinal Symptom Research Studies Aimed at the General Population. 2013. Available online: https:\/\/www.evidencepartners.com\/resources\/methodological-resources."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/00004850-199905030-00006","article-title":"Clomipramine treatment of delusional disorder, somatic type","volume":"14","author":"Wada","year":"1999","journal-title":"Int. Clin. Psychopharmacol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0278-5846(98)00098-0","article-title":"Possible association between delusional disorder, somatic type and reduced regional cerebral blood flow","volume":"23","author":"Wada","year":"1999","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0278-5846(03)00118-0","article-title":"A case of delusional disorder, somatic type with remarkable improvement of clinical symptoms and single photon emission computed tomograpy findings following modified electroconvulsive therapy","volume":"27","author":"Ota","year":"2003","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/hup.590","article-title":"Paroxetine treatment of delusional disorder, somatic type","volume":"19","author":"Hayashi","year":"2004","journal-title":"Hum. Psychopharmacol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1177\/0269881107082905","article-title":"Delusional disorder, somatic type treated with aripiprazole-mirtazapine combination","volume":"22","author":"Dimopoulos","year":"2008","journal-title":"J. Psychopharmacol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1055\/s-2008-1062697","article-title":"Successful treatment of delusional disorder of the somatic type or \u201cdelusional parasitosis\u201d with olanzapine","volume":"41","author":"Bosmans","year":"2008","journal-title":"Pharmacopsychiatry"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1016\/j.pnpbp.2008.09.014","article-title":"Striatal lesions in delusional parasitosis revealed by magnetic resonance imaging","volume":"32","author":"Huber","year":"2008","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.genhosppsych.2008.07.004","article-title":"Extremely grotesque somatic delusions in a patient of delusional disorder and its response to risperidone treatment","volume":"31","author":"Akahane","year":"2009","journal-title":"Gen. Hosp. Psychiatry"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/WNF.0b013e3181c1cfe4","article-title":"Successful treatment by paroxetine of delusional disorder, somatic type, accompanied by severe secondary depression","volume":"33","author":"Hayashi","year":"2010","journal-title":"Clin. Neuropharmacol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.pnpbp.2010.06.022","article-title":"Delusional infestation: Neural correlates and antipsychotic therapy investigated by multimodal neuroimaging","volume":"34","author":"Freudenmann","year":"2010","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"ref_49","first-page":"215732","article-title":"Supersensitivity psychosis and its response to asenapine in a patient with delusional disorder","volume":"2014","author":"Rajkumar","year":"2014","journal-title":"Case Rep. Psychiatry"},{"key":"ref_50","first-page":"1014","article-title":"Successful Treatment of Delusional Disorder, Persecutory Type with Lurasidone: A Case Report","volume":"2","author":"Davis","year":"2015","journal-title":"J. Schizophr. Res."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/WNF.0000000000000207","article-title":"Two cases of oral somatic delusions ameliorated with brain perfusion asymmetry: A case report","volume":"40","author":"Umezaki","year":"2017","journal-title":"Clin. Neuropsychopharmacol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/S0893-133X(01)00421-3","article-title":"Delusional disorder: Molecular genetic evidence for dopamine psychosis","volume":"26","author":"Morimoto","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.mehy.2006.07.061","article-title":"Delusional parasitosis and the dopamine transporter. A new insight of etiology?","volume":"68","author":"Huber","year":"2007","journal-title":"Med. Hypotheses"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1017\/S1461145704004110","article-title":"Do we still believe in the dopamine hypothesis? New data bring new evidence","volume":"7","year":"2004","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.nurx.2005.12.003","article-title":"How antipsychotics work\u2014From receptors to reality","volume":"3","author":"Kapur","year":"2006","journal-title":"NeuroRx"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.2174\/138161209788957528","article-title":"Mechanisms underlying psychosis and antipsychotic treatment response in schizophrenia: Insights from PET and SPECT imaging","volume":"15","author":"Howes","year":"2009","journal-title":"Curr. Pharm. Des."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/YIC.0000000000000306","article-title":"A systematic review of studies with clinician-rated scales on the pharmacological treatment of delusional disorder","volume":"35","author":"Peralta","year":"2020","journal-title":"Int. Clin. Psychopharmacol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S0893-133X(98)00108-0","article-title":"5-HT modulation of dopamine release in basal ganglia in psilocybin-induced psychosis in man\u2014A PET study with [11 C] raclopride","volume":"20","author":"Vollenweider","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1093\/schbul\/sbs145","article-title":"Current paranoid thinking in patients with delusions: The presence of cognitive-affective biases","volume":"39","author":"Freeman","year":"2013","journal-title":"Schizophr. Bull."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0010-440X(99)90118-9","article-title":"Factor analysis of delusional disorder symptomatology","volume":"40","author":"Serretti","year":"1999","journal-title":"Compr. Psychiatry"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.comppsych.2012.08.002","article-title":"Empirical redefinition of delusional disorder and its phenomenology: The DELIREMP study","volume":"54","author":"Haro","year":"2013","journal-title":"Compr. Psychiatry"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2174\/1874354401509010017","article-title":"Structural and Functional Neuroimaging findings in Delusional Disorder and Therapeutic Implications","volume":"9","author":"Catalan","year":"2015","journal-title":"Open Psychiatry J."},{"key":"ref_63","first-page":"12","article-title":"A Psychopathological Comparison between Delusional Disorder and Schizophrenia","volume":"63","author":"Cervilla","year":"2017","journal-title":"Can. J. Psychiatry"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1017\/S0033291716001501","article-title":"Delusional disorder and schizophrenia: A comparative study across multiple domains","volume":"46","author":"Peralta","year":"2016","journal-title":"Psychol. Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/schbul\/sbt203","article-title":"Delusional Disorder as a Partial Psychosis","volume":"40","author":"Opjordsmoen","year":"2014","journal-title":"Schizophr. Bull."},{"key":"ref_66","unstructured":"Gonz\u00e1lez-Castro, N. (2014). Trastorno Delirante: \u00bfEs Realmente Diferente de la Esquizofrenia?. [Ph.D. Thesis, Universitat Aut\u00f2noma de Barcelona, BCN]."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1600-0447.1997.tb00390.x","article-title":"Organic delusional disorder in psychiatric in-patients: Comparison with delusional disorder","volume":"95","author":"Lo","year":"1997","journal-title":"Acta Psychiatr. Scand."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/BF03159710","article-title":"Delusional thinking and cognitive disorder","volume":"40","author":"Maher","year":"2005","journal-title":"Integr. Phychol. Behav. Sci."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/schbul\/sbw191","article-title":"Transdiagnostic Extension of Delusions: Schizophrenia and Beyond","volume":"43","author":"Bebbington","year":"2017","journal-title":"Schizophr. Bull."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1080\/13607860802343118","article-title":"Delusional disorder in old age and the risk of developing dementia\u2014A nationwide register-based study","volume":"12","author":"Lopez","year":"2008","journal-title":"Aging Ment. Health"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.schres.2021.01.015","article-title":"Effectiveness of pharmacotherapies for delusional disorder in a Swedish national cohort of 9076 patients","volume":"228","author":"Taipale","year":"2021","journal-title":"Schizophr. Res."},{"key":"ref_72","first-page":"239","article-title":"Treatment-resistant schizophrenia","volume":"39","author":"Elkis","year":"2016","journal-title":"Psychiatr. Clin."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Gillespie, A.L., Samanaite, R., Mill, J., Egerton, A., and MacCabe, J.H. (2017). Is treatment-resistant schizophrenia categorically distinctfrom treatment-responsive schizophrenia? A systematic review. BMC Psychiatry, 17.","DOI":"10.1186\/s12888-016-1177-y"}],"container-title":["Behavioral Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-328X\/11\/10\/141\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:18:08Z","timestamp":1760167088000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-328X\/11\/10\/141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,19]]},"references-count":73,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,10]]}},"alternative-id":["bs11100141"],"URL":"https:\/\/doi.org\/10.3390\/bs11100141","relation":{},"ISSN":["2076-328X"],"issn-type":[{"value":"2076-328X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,19]]}}}